The US Food and Drug Administration (FDA) on Friday released draft guidance describing how FDA plans to implement the requirements for the electronic submission of Risk Evaluation and Mitigation ...
The US Food and Drug Administration (FDA) has released a new draft guidance document on a new digital medical device submission system. The system, known as the eCopy Program, is soon to be required ...
Predetermined Change Control Plans, Lifecycle Expectations, and New Transparency Obligations - The FDA has been steadily laying ...
FDA recently issued two draft guidance documents discussing: (1) the use of artificial intelligence (AI) to produce information to support a regulatory decision about a drug or biological product’s ...
The Food and Drug Administration has issued new draft guidance providing updated and detailed recommendations for how medical device makers should address cybersecurity risk in the premarket of their ...
GENIE is the first real-time, LLM-agnostic intelligence engine that converts complex regulations into machine-executable logic for compliance enforcement. i-GENTIC introduces a level of trust and ...
Guided Therapeutics, Inc. (Pink Sheets: GTHP) is the maker of a rapid and painless testing platform based on its patented biophotonic technology that utilizes light for the early detection of disease ...
Morning Overview on MSN
FDA to pilot real-time tracking of clinical trials to speed safety feedback
When a patient in an early-phase drug trial experiences a serious side effect today, weeks or even months can pass before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results